Laura Soucek receives an ERC Advanced Grant to maximize the clinical and preclinical use of the first viable MYC inhibitor

by VHIO

Laura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies Group, has received a European Research Council (ERC) Adv...

Read more

New mechanism discovered for the life-threatening arrhythmias in Andersen-Tawil syndrome

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

The study demonstrates that a specific genetic mutation (C122Y) in the Kir2.1 potassium channel alters the function not only of Kir2.1 but also of the main cardiac sodium channel NaV1.5, thus establis...

Read more

Expedition begins to chart the invisible biodiversity of Pyrenean lakes

by Centre for Genomic Regulation

Researchers from Spain, Andorra and France have begun efforts to chart the biodiversity of microorganisms living under the surface of 300 different lakes across the Pyrenees. The initiative will shed ...

Read more

CNIC scientists identify therapeutic targets for the prevention of heart injury linked to cancer treatment

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

The study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxic...

Read more

Explican los fundamentos moleculares de la discinesia ciliar primaria, una enfermedad rara respiratoria

by INCLIVA

Esta patología afecta tanto a niños como a adultos y provoca la inflamación crónica de las vías respiratorias aéreas (fosas nasales, boca y faringe)

Read more

Palobiofarma announces the completion the Phase II clinical trial with its investigational therapy PBF-680 in chronic obstructive pulmonary disease (COPD) patients

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visit” of the Phase II trial investigating the safety and preliminary efficacy of PBF-680 in moderate to severe COPD patients.

Read more

Una beca europea permitirá avanzar en el diagnóstico y tratamiento de las Enfermedades Vasculares Portosinusoidales

by Fundació Clínic per a la Recerca Biomèdica

El proyecto RiTA (Enfermedades Vasculares PortoSinusoidales: Estratificación de Riesgos y Enfoques Terapéuticos, por sus siglas en inglés), que ha empezado en abril 2024, tiene como objetivo princi...

Read more

Laminar Pharma opens a new seek capital round of up to seven million euros

by Laminar Pharma

Laminar Pharma opens a new financing round of up to seven million euros. The objective is to finish financing the development of its drug LAM561 against the most aggressive and common brain cancer, gl...

Read more

CNIC scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndrome

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

It has been examined whether atherosclerosis can be avoided in HGPSrev mice by suppressing progerin and restoring lamin A either in endothelial cells or in vascular smooth muscle cells, two types of c...

Read more

Cantabria joins the European FAITHFUL project for early detection of heart failure with artificial intelligence

by Instituto de Investigación Marqués de Valdecilla

1.7 million, the project will run until the end of 2025 and will involve leading international institutions in the sector.

Read more

Un estudio liderado por el Hospital Virgen Macarena es publicado en ‘The Lancet Microbe’

by Hospital Universitario Virgen de la Macarena

El estudio PROBAC-EC demuestra que la estructura poblacional de la bacteria Escherichia coli en pacientes con infección grave es altamente compleja y que las características de virulencia y resisten...

Read more

El IBSAL, en un consorcio europeo dotado con 2,5 millones para promover la fabricación de terapias celulares

by Instituto de Investigación Biomédica de Salamanca - IBSAL

Abren la posibilidad de explorar una nueva estrategia de modificación celular que puede ser enormemente atractiva para la próxima generación de medicamentos de terapia avanzada

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

CRB Health Tech realiza el primer cierre...

by CRB Inverbío SA SGECR

Con la incorporación de Sanitas y las suscripciones ya firmadas con a...

Photos Stream